CLENE INC C/WTS 30/12/2025 (TO PUR COM) | 10-Q: FY2025 Q2 Revenue: USD 27 K

Revenue: As of FY2025 Q2, the actual value is USD 27 K.

EPS: As of FY2025 Q2, the actual value is USD -0.78.

Segment Revenue

• Product Revenue: $1 thousand for the three months ended June 30, 2025, compared to $64 thousand for the same period in 2024, representing a decrease of 98%.
• Royalty Revenue: $26 thousand for the three months ended June 30, 2025, compared to $27 thousand for the same period in 2024, representing a decrease of 4%.

Operational Metrics

• Net Loss: $7.4 million for the three months ended June 30, 2025, compared to $6.8 million for the same period in 2024, representing an increase of 9%.
• Research and Development Expense: $3.5 million for the three months ended June 30, 2025, compared to $4.2 million for the same period in 2024, representing a decrease of 15%.
• General and Administrative Expense: $2.4 million for the three months ended June 30, 2025, compared to $3.3 million for the same period in 2024, representing a decrease of 28%.

Cash Flow

• Net Cash Used in Operating Activities: $9.8 million for the six months ended June 30, 2025, compared to $13.4 million for the same period in 2024.
• Net Cash Provided by Financing Activities: $4.8 million for the six months ended June 30, 2025, compared to $9 thousand for the same period in 2024.

Future Outlook and Strategy

• Core Business Focus: The company plans to submit an NDA for CNM-Au8 by the end of 2025 under an accelerated approval pathway, contingent on the results of ongoing studies and regulatory feedback.
• Non-Core Business: The company is exploring additional funding options, including equity and debt financing, to support its operations and strategic initiatives.